Brian Sun serves as Executive at Turning Point Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Brian Sun has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 17, 2022 involved selling 45,000 shares valued at $3.4M.
Brian Sun currently holds 45,000 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Sun has been a net neutral trader of TPTX stock. They have purchased $0 and sold $0 worth of shares.
Brian Sun's most recent insider trade was on Aug 17, 2022, when they sold 45,000 shares at $76.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |